Clinical trial
2-Hydroxybenzylamine: Multiple Dosing Study in Healthy Humans
NCT03555682 is registered in ClinicalTrials.gov with Metabolic Technologies Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 2-Hydroxybenzylamine: Multiple Dosing Study in Healthy Humans
- Lead sponsor
- Metabolic Technologies Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 23, 2018
- Completion date
- May 10, 2019
- Enrollment
- 18 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy volunteers